Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    8565306 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
Conditions: HIV Infections;   Helminthiasis
Interventions: Drug: Albendazole;   Drug: Placebo
2 Completed Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
Conditions: HIV Infections;   Helminthiasis
Interventions: Drug: Albendazole;   Drug: Praziquantel;   Drug: Current standard of care in Kenya
3 Completed The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis Bacteria
Conditions: Intestinal Helminth Infection;   Filarial Infection
Intervention:

Indicates status has not been verified in more than two years